Low molecular weight advanced glycation end products predict mortality in asymptomatic patients receiving chronic haemodialysis

摘要

Background. Advanced glycation end products (AGEs) have biological properties that may contribute to the premature cardiovascular mortality of haemodialysis patients. This study examines the hypothesis that low molecular weight forms of fluorescent AGEs (LMW fluorescence) predict mortality in haemodialysis patients.